BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28986308)

  • 21. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
    Guo XF; Gao JL; Li JM; Li D
    Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol.
    Henkel J; Alfine E; Saín J; Jöhrens K; Weber D; Castro JP; König J; Stuhlmann C; Vahrenbrink M; Jonas W; Kleinridders A; Püschel GP
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30231595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
    Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
    Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
    World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice.
    Yan C; Zhang Y; Zhang X; Aa J; Wang G; Xie Y
    Biomed Pharmacother; 2018 Sep; 105():274-281. PubMed ID: 29860219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet.
    Valenzuela R; Espinosa A; Llanos P; Hernandez-Rodas MC; Barrera C; Vergara D; Romero N; Pérez F; Ruz M; Videla LA
    Food Funct; 2016 Jan; 7(1):140-50. PubMed ID: 26471014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content.
    Espinosa A; Valenzuela R; González-Mañán D; D'Espessailles A; Guillermo Gormaz J; Barrera C; Tapia G
    Arch Latinoam Nutr; 2013 Mar; 63(1):29-36. PubMed ID: 24167955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice.
    Saraswathi V; Perriotte-Olson C; Ganesan M; Desouza CV; Alnouti Y; Duryee MJ; Thiele GM; Nordgren TM; Clemens DL
    J Nutr Biochem; 2017 Apr; 42():149-159. PubMed ID: 28187366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice.
    Sun X; Duan X; Wang C; Liu Z; Sun P; Huo X; Ma X; Sun H; Liu K; Meng Q
    Eur J Pharmacol; 2017 Jul; 806():75-82. PubMed ID: 28414056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M; Nishio Y; Sekine O; Nagai Y; Maeno Y; Ugi S; Yoshizaki T; Morino K; Kume S; Kashiwagi A; Maegawa H
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E293-304. PubMed ID: 23715726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
    Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Docosahexaenoic acid prevents trans-10, cis-12-conjugated linoleic acid-induced nonalcoholic fatty liver disease in mice by altering expression of hepatic genes regulating fatty acid synthesis and oxidation.
    Fedor DM; Adkins Y; Mackey BE; Kelley DS
    Metab Syndr Relat Disord; 2012 Jun; 10(3):175-80. PubMed ID: 22242926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
    Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA
    Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD.
    Miyata M; Matsushita K; Shindo R; Shimokawa Y; Sugiura Y; Yamashita M
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32604760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.